About
Sarborg, founded in 2024 in the Cayman Islands, develops AI agents to support pharmaceutical companies in drug repositioning and clinical trial decision optimization.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 1
Founders / team· 1
Funding history
- 2025-08Seed$10M
Investors · Corvus CapitalSource · SVTR Weekly #120
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Sarborg
AI agents that help pharmaceutical companies optimize drug repurposing and clinical trial decisions
Seed · $10M · 2025-08
$10M
United States
BusinessLatest roundTotal raisedDate- BioPhy
AI-generated quantitative metrics on the likelihood of success of drugs and clinical trials
Seed · $5M · 2023-11
$5M - Alleviate Health
AI agents for clinical trial patient recruitment and screening
Seed · $4M · 2025-10
$4M - Valinor
Models trained on multi-omics/longitudinal clinical data to predict clinical trial efficacy and stratify patients
Seed · $13M · 2025-12
$13M
China
BusinessLatest roundTotal raisedDate- Purui Intelligence
AI-driven platform for end-to-end clinical trial automation and results delivery.
Series A · $14M · 2026-06
$14M - 若生智能
AI search agent for pharma companies, physicians and biotech investors that produces cited research reports from PubMed and clinical guidelines
Series A · $7M · 2025-02
$7M - Insilico Medicine
AI drug discovery company that uses generative models for target discovery and molecular design, and has advanced multiple drug candidates into clinical trials
Series D+ · $210M · 2025-03
$210M
Europe
BusinessLatest roundTotal raisedDate- Perceptic
AI agents that connect research, clinical and operational data for pharma in drug discovery, trial design and asset evaluation
Seed · $12M · 2026-05
$12M - IgniteData
Automatically transfers patient data from electronic health records to clinical trial electronic data capture systems
Seed · $8M · 2024-06
$8M - Research Grid
Automated workflow platform that improves clinical trial efficiency
Seed · $6M · 2024-11
$6M
Other / unspecified
BusinessLatest roundTotal raisedDate- Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - QuantHealth
Helps researchers maximize clinical trial success rates
Series A · $17M · 2024-01
$17M - Plaio
Supply chain software for pharmaceutical companies, including demand forecasting, production planning and procurement
Undisclosed · $5M · 2024-08
$5M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Kaya VC
2 Life Sciences deals in the last 24 months · 2 at a nearby stage · 1 in Other
Request intro →Heran Partners
2 Life Sciences deals in the last 24 months · 1 at a nearby stage · 1 in Other
Request intro →Soulmates Ventures
2 Life Sciences deals in the last 24 months · 2 at a nearby stage · 1 in Other
Request intro →Specialist VC
2 Life Sciences deals in the last 24 months · 2 at a nearby stage · 1 in Other
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.